2m 2m 2m 2m 2m 2m 2m
Merck (MRK)
NYSE
$139.65+$0.11 (+0.08%)
Price as of Oct 05, 2026 7:59 PM EDT- $356.0BMarket Cap
- 61.75%1-Year Change
- Drug Manufacturers - GeneralIndustry
Merck (MRK)
$139.65+$0.11 (+0.08%)
MRK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $139.54 | ||
Change | -$4.76 (-3.30%) | ||
Open | $143.67 | ||
High | $144.06 | ||
Low | $138.80 | ||
Previous Close | $144.30 | ||
Volume | 9,485,737 | ||
30-Day Average Volume | 10,112,180 | ||
1-Week Change | -6.15% | ||
1-Month Change | -6.63% | ||
1-Year Change | 61.75% | ||
3-Year Change | 47.59% | ||
5-Year Change | 99.26% | ||
Fundamentals | |||
Shares Outstanding | 2.5B | ||
Total Assets | $129.8B | ||
Market Cap | $356.0B | ||
Enterprise Value | $403.1B | ||
Period: QTR TTM FY | |||
Revenue | $16.6B | ||
Net Income | -$1.3B | ||
Free Cash Flow | $4.5B | ||
EBIT | -$681.0M | ||
EBITDA | -$82.0M | ||
Net Working Capital | $8.9B | ||
EPS | -$0.54 | ||
Enterprise Value/EBITDA | -4,915 | ||
Enterprise Value/Revenue | 24 | ||
P/B | 8 | ||
P/E | -267 | ||
PEG | -4 | ||
Price/Free Cash Flow | 80 | ||
Price/Operating Cash Flow | 66 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.44% | ||
Trailing Annual Dividend Yield | 2.44% | ||
Ex-Dividend Date | 09/15/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield